Lonza | LONN - Loan Capital


Lonza reported CHF3.88B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Akzo Nobel EUR 5.5B 743M Jun/2026
Alcon AG USD 4.65B 491M Jun/2026
Almirall EUR 303.77M 21.04M Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
BASF EUR 18.83B 1.08B Jun/2026
Bayer EUR 31.16B 480M Jun/2026
Beiersdorf EUR 117M 15M Dec/2025
Covestro EUR 1.67B 408M Dec/2025
Demant DKK 13.13B 5.86B Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.82B 83.04M Jun/2026
Geberit CHF 1.35B 25.4M Sep/2025
Genmab DKK 4.96B 28M Jun/2026
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GN Store Nord DKK 8.11B 4M Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Johnson Matthey GBP 1.35B 2M Jun/2026
Merck EUR 11.21B 406M Jun/2026
Novartis USD 37.49B 42M Jun/2026
Philips EUR 6.32B 575M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Sika AG CHF 4.13B 1.4B Dec/2025
Smith & Nephew USD 3.21B 85M Jun/2026
Solvay EUR 1.82B 11M Jun/2026
UCB EUR 2.18B 634M Dec/2025